The Swiss contract development and manufacturing organization will more than double its U.S. footprint by acquiring the Merck ...
Neurocrine Biosciences will conduct a new study for the rare disease drug Vykat to explore dosing and safety in patients with ...
Roy Jakobs, CEO of Royal Philips: “We delivered an excellent 8% comparable order intake, led by broad-based order momentum in Diagnosis & Treatment, and 3% comparable sales growth in the third quarter ...
Aarvik Therapeutics (Aarvik), an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines ...
Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative ...
Keith A. Goldan to retire as CFO and remain with the Company through year-end to support the transition - NEW YORK, Nov. 02, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results